Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uveal Melanoma × tremelimumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 10 Carcinoma, Non-Small-Cell Lung 5 Liver Neoplasms 4 Small Cell Lung Carcinoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Seminoma 1 Pancreatic Neoplasms 1 Nonseminomatous germ cell tumor 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms, Germ Cell and Embryonal 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Mesothelioma 1 Lung Cancer Metastatic 1 Liver Cirrhosis 1 Hydronephrosis 1 Germinoma 1 Fallopian Tube Neoplasms 1 Dysgerminoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Adenocarcinoma, Follicular 1 Adenocarcinoma Of Esophagus 1

Interventions

Nivolumab 5 Cyclophosphamide 4 pembrolizumab 3 tebentafusp 2 fludarabine phosphate 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 ulixertinib 1 trametinib 1 relatlimab 1 omipalisib 1 olaparib 1 fludarabine 1 cemiplimab 1 binimetinib 1 Watchful Waiting 1 Vorinostat 1 Valproic Acid 1 TYRP1 protein, human 1 Sunitinib 1 Spinal Puncture 1 Radiosurgery 1 Protein Kinase C 1 Practice Guidelines as Topic 1 Methods 1 LY2940680 1 Interleukin-2 1 Interleukin-13 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡